Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression

Applied and Environmental Microbiology

Volumn 74, Issue 22, 2008, Pages 7051-7055

  Rajasekaran, Parthiban ^a   Seleem, Mohamed N ^b   Contreras, Andrea ^a   Purwantini, Endang ^c   Schurig, Gerhardt G ^a   Sriranganathan, Nammalwar ^a   Boyle, Stephen M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS;

ANTIBIOTIC RESISTANCES; BRUCELLA; ENVIRONMENTALLY SAFES; GREEN FLUORESCENT PROTEINS; OVEREXPRESSION; VACCINE STRAINS;

ANTIGENS;

BACTERIAL ANTIGEN; BRUCELLA VACCINE; GREEN FLUORESCENT PROTEIN; LEUCINE;

AMINO ACID; ANTIBIOTIC RESISTANCE; ANTIGEN; BACTERIUM; GENE EXPRESSION; GENETIC MARKER; PLASMID; VACCINE; VIRULENCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BIOSYNTHESIS; BRUCELLA ABORTUS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE OVEREXPRESSION; IMMUNE RESPONSE; LEUB GENE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; STRAIN IDENTIFICATION;

ANIMALS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; GENE DOSAGE; GENES, REPORTER; GENETIC COMPLEMENTATION TEST; GREEN FLUORESCENT PROTEINS; LEUCINE; MICE; PLASMIDS;

BOS; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS;

EID: 55949128311     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01511-08     Document Type: Article

References (17)

1. Anonymous. 1998. Guidance for human somatic cell therapy and gene therapy. Hum. Gene Ther. 9:1513-1524.
2. Bacon, G. A., T. W. Burrows, and M. Yates. 1951. The effects of biochemical mutation on the virulence of Bacterium typhosum; the loss of virulence of certain mutants. Br. J. Exp. Pathol. 32:85-96.
3. Bange, F. C., A. M. Brown, and W. R. Jacobs, Jr. 1996. Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect. Immun. 64:1794-1799.
4. Essenberg, R. C., and Y. K. Sharma. 1993. Cloning of genes for proline and leucine biosynthesis from Brucella abortus by functional complementation in Escherichia coli. J. Gen. Microbiol. 139:87-93.
5. 4-type pyruvate carboxylases. Appl. Environ. Microbiol. 72:7785-7792.
6. Le Garrec, Y., N. Garrido-Calderon, and C. Pilet. 1976. Influence of the mouse genotype on the sensitivity to Brucella abortus 544. Dev. Biol. Stand. 31:287-292.
7. Lemaitre, J. P., H. Echchannaoui, G. Michaut, C. Divies, and A. Rousset. 1998. Plasmid-mediated resistance to antimicrobial agents among listeriae. J. Food Prot. 61:1459-1464.
8. Marx, C. J., and M. E. Lidstrom. 2002. Broad-host-range cre-lox system for antibiotic marker recycling in gram-negative bacteria. BioTechniques 33:1062-1067.
9. McQuiston, J. R., G. G. Schurig, N. Sriranganathan, and S. M. Boyle. 1995. Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol. Biol. 47:143-148.
10. Plommet, M. 1991. Minimal requirements for growth of Brucella suis and other Brucella species. Zentralbl. Bakteriol. 275:436-450.
11. Quenee, L., D. Lamotte, and B. Polack. 2005. Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient gene deletion in Pseudomonas aeruginosa. BioTechniques 38:63-67.
12. Ramamoorthy, S., N. Sanakkayala, R. Vemulapalli, R. B. Duncan, D. S. Lindsay, G. S. Schurig, S. M. Boyle, R. Kasimanickam, and N. Sriranganathan. 2007. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens. Int. J. Parasitol. 37:1521-1529.
13. Ramamoorthy, S., N. Sanakkayala, R. Vemulapalli, N. Jain, D. S. Lindsay, G. S. Schurig, S. M. Boyle, and N. Sriranganathan. 2007. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens. Int. J. Parasitol. 37:1531-1538.
14. Seleem, M. N., R. Vemulapalli, S. M. Boyle, G. G. Schurig, and N. Sriranganathan. 2004. Improved expression vector for Brucella species. BioTechniques 37:740.
15. Vemulapalli, R., Y. He, S. M. Boyle, N. Sriranganathan, and G. G. Schurig. 2000. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect. Immun. 68:3290-3296.
16. Vemulapalli, R., Y. He, N. Sriranganathan, S. M. Boyle, and G. G. Schurig. 2002. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines. Vet. Microbiol. 90:521-532.
17. Verch, T., Z. K. Pan, and Y. Paterson. 2004. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines. Infect. Immun. 72:6418-6425.